Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03400150 · ClinicalTrials.gov registry record · NA
BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007
A NA study, sponsored by BioProtect.
- Completed
- Registry status
- NA
- Development phase
- 222
- Enrollment target
NCT03400150: Completed NA study, sponsored by BioProtect.
NCT03400150 is a NA study that has completed, run by BioProtect. The registered enrollment target is 222 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03400150, a NA study, has completed, sponsored by BioProtect.
- COMPLETED
- Registry status
- NA
- Development phase
- 222 participants
- Enrollment target
Study Summary
The BioProtect Balloon Implant™ System is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of the balloon to reduce the radiation dose delivered to the anterior rectum. The balloon composed of a biodegradable material that maintains that space for the entire course of prostate radiotherapy treatment and is completely absorbed by the patient's body over time.
Interventions
- OTHER Control
- DEVICE balloon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 222 participants |
| Start Date | 2018-01-03 |
| Est. Completion | 2021-12-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03400150
The ClinicalTrials.gov registry entry for NCT03400150 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 222 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioProtect, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03400150 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03400150 about?
NCT03400150 is a clinical study titled "BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007". The BioProtect Balloon Implant™ System is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of the balloon to reduce the radiation dose delivered to the anterior rectum. The balloon com...
What is the current status of trial NCT03400150?
This trial is currently completed. It is a NA study. The enrollment target is 222 participants. The study started on 2018-01-03. Estimated completion is 2021-12-10.
What interventions are being tested in trial NCT03400150?
The interventions under investigation include: Control (OTHER), balloon (DEVICE).
Who is sponsoring clinical trial NCT03400150?
This trial is sponsored by BioProtect, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.